Back to search

Article

Oxycodone/naloxone versus Tapentadol in real-world chronic non-cancer pain management: a prospective controlled and pharmacogenetic study

2024-01-31

Abstract excerpt

<h4>Background: </h4> and purpose: Tapentadol (TAP) and oxycodone/naloxone (OXN) are available formulations that potentially offer improved gastrointestinal tolerability. However, real-world studies in chronic non-cancer pain (CNCP) remain scarce. The aim is to analyse their benefit/risk profiles and the influence of pharmacogenetic markers in daily pain practice. Experimental approach: A prospective, controlled s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
975ea959-e1b3-52ed-94c5-a5a962bc5751
DOI
10.22541/au.170666297.73406141/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Oxycodone/naloxone versus Tapentadol in real-world chronic non-cancer pain management: a prospective controlled and pharmacogenetic studyDOI 10.22541/au.170666297.73406141/v1
Select a neighboring publication to make it the new centre.